Skip to main content

CITADEL ADVISORS LLC

Position in LFCR — Lifecore Biomedical, Inc. \De\

CIK 1423053 MIAMI, FL

Position in LFCR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
-$148,188 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
19 quarters on record

Common Shares in LFCR Over Time

Shares Held

Position Value (USD)

Derivatives in LFCR

reported options exposure · as of Mar 31, 2026
CallValue
$158,844
CallShares
42,700
PutValue
$38,316
PutShares
10,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $927,090,430 across 59 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open

All Filings in LFCR

Export CSV
35 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $38,316 10,300
2026-03-31 $158,844 42,700
2025-12-31 $566,056 69,200
2025-12-31 $148,188 18,116
2025-09-30 $491,294 66,752
2025-06-30 $238,638 29,389
2025-03-31 $214,881 30,523
2025-03-31 $9,856 1,400
2024-06-30 $18,468 3,600
2024-06-30 $217,701 42,437
2024-06-30 $21,546 4,200
2024-03-31 $158,238 29,800
2024-03-31 $84,960 16,000
2023-09-30 $256,700 34,000
2023-09-30 $568,672 75,321
2023-09-30 $335,220 44,400
2023-06-30 $408,074 42,200
2023-06-30 $661,485 68,406
2023-06-30 $490,269 50,700
2023-03-31 $96,390 25,500
2023-03-31 $17,388 4,600
2022-12-31 $20,736 3,200
2022-12-31 $542,731 83,755
2022-12-31 $43,416 6,700
2022-06-30 $174,863 17,539
2022-03-31 $128,538 11,100
2022-03-31 $531,058 45,860
2021-12-31 $115,440 10,400
2021-09-30 $97,732 10,600
2021-06-30 $563,647 50,102
2021-06-30 $257,625 22,900
2021-03-31 $133,560 12,600
2021-03-31 $642,656 60,628
2020-12-31 $637,925 58,795
2020-03-31 $202,824 23,340